Abiopharma

🔍 GARCIA ERNEST C. II (Executive)

Company: CARVANA CO. (CVNA)

Report Date: 2026-05-01

Detailed Transactions and Holdings:

• Sold 4,000,000 shares of Covered Call Option (Obligation to Sell) at $400.0 per share (Derivative)
  Date: 2026-04-17 | Code: E | Expires: 2026-04-17 | equity_swap_involved: false | transaction_form_type: 5 | Footnotes: F1, F2, F3, F1
• Sold 2,000,000 shares of Covered Call Option (Obligation to Sell) at $450.0 per share (Derivative)
  Date: 2026-05-01 | Code: S | Expires: 2027-05-21 | Exercise: 2027-05-21 | equity_swap_involved: false | shares_owned_after: 2,000,000.00 | transaction_form_type: 4 | Footnotes: F4, F4, F4, F1
• Sold 2,000,000 shares of Covered Call Option (Obligation to Sell) at $500.0 per share (Derivative)
  Date: 2026-05-01 | Code: S | Expires: 2027-05-21 | Exercise: 2027-05-21 | equity_swap_involved: false | shares_owned_after: 2,000,000.00 | transaction_form_type: 4 | Footnotes: F4, F4, F4, F1

Footnotes:

• F1: The covered call options represented the option holder's right to purchase, and the option seller's obligation to sell, the underlying shares at the specified strike price. The covered call options were held directly by ECG II SPE, LLC ("E-SPE"), an entity wholly owned and controlled by Mr. Garcia.
• F2: This Form 4 is being filed on a voluntary basis to report, in advance, the expiration of the covered call options that would otherwise be reportable on Form 5 for the year ended December 31, 2026.
• F3: On May 9, 2025, E-SPE entered into a European-style covered call option transaction with an unaffiliated third-party purchaser. Under the terms of the transaction, E-SPE sold 4,000,000 covered call options, each referencing one share of the Issuer's Class A common stock, exercisable only on the expiration date, with an expiration date of April 17, 2026. In exchange for selling these options, E-SPE received a cash premium of $24.75 per option, which was paid in May 2025. The options were out of the money on the expiration date and expired without being exercised.
• F4: On May 1, 2026, E-SPE entered into a European-style covered call option transaction with an unaffiliated third-party purchaser. Under the terms of this transaction, E-SPE sold 4,000,000 covered call options, comprised of 2,000,000 covered call options with an exercise price of $450.00 and 2,000,000 covered call options with an exercise price of $500.00, each referencing one share of the Issuer's Class A common stock, with an expiration date of May 21, 2027. In exchange for selling these options, E-SPE received a cash premium of $68.0575 per option.
• F5: E-SPE pledged 4,000,000 shares of the Issuer's Class B common stock and 5,000,000 units of Carvana Group, LLC Class A units (collectively, the "Pledged Shares") to secure its obligations under the transaction. During the term of the pledge, E-SPE retains the right to vote the Pledged Shares and retains investment/dispositive power over the Pledged Shares, subject to the terms of the pledge arrangements.